RECENT PAST NEWS IN MDR-TB

1 / 4 / 6 x 24 Campaign launched to rally energy, political will, funding needed to fight TB

PAN-TB collaboration to advance investigational TB drug regimens to Phase 2 clinical trials

Sequencing effort aims to improve drug-resistant TB diagnosis, treatment

New blood test can help doctors diagnose TB and monitor treatment

WHO issues rapid communication on updated guidance for the treatment of drug-resistant tuberculosis

20% of multi-drug resistant tuberculosis cases in children could be averted by household testing

Rise of drug-resistant tuberculosis is hidden in plain sight

Updated WHO 6-Month MDR-TB Regimen

Possible new method identified to assess severity of TB infection

Drug-resistant TB: Rollout of shorter regimen hits a snag in South Africa

Promising new target for tuberculosis treatment

Genomic signatures of pre-resistance in Mycobacterium tuberculosis

New TB Funding Trends Report Finds that Funding for TB Research in 2020 Reached Only US$915 Million

South Africa sets another example of success in beating tuberculosis

Global individual patient data platform for drug-resistant tuberculosis treatment

UNITE4TB: a new consortium for clinical drug and regimen development for TB.

Assessment of epi and genetic and clinical outcomes of resistance to bedaquiline

Clinical trial results offer hope to DR-TB patients with short, effective treatment

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

EndTB clinical trial for multi drug-resistant TB completes enrollment